Kirjojen hintavertailu. Mukana 12 390 323 kirjaa ja 12 kauppaa.

Kirjailija

Kenneth L. Minaker

Kirjat ja teokset yhdessä paikassa: 2 kirjaa, julkaisuja vuosilta 2003-2012, suosituimpien joukossa Alzheimer Disease. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

2 kirjaa

Kirjojen julkaisuhaarukka 2003-2012.

Alzheimer Disease

Alzheimer Disease

Gérard Emilien; Cécile Durlach; Kenneth L. Minaker; Bengt Winblad; Serge Gauthier; Jean-Marie Maloteaux

Springer Basel
2012
nidottu
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.
Alzheimer Disease

Alzheimer Disease

Gérard Emilien; Cécile Durlach; Kenneth L. Minaker; Bengt Winblad; Serge Gauthier; Jean-Marie Maloteaux

Birkhauser Verlag AG
2003
sidottu
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.